Medical vs Wellness Devices: What Really Makes the Difference?

MedDevice by Design with Mark Drlik and Ariana Wilson
Resources

Medical vs Wellness Devices: What Really Makes the Difference?

YouTube video thumbnail

The line between consumer wearables and regulated healthcare products is often unclear. In this episode of MedDevice by Design, Ariana Wilson and Mark Drlik break down medical vs wellness devices and explain why two products with identical hardware can fall into completely different regulatory categories.

Many people wear fitness trackers or smartwatches every day. However, not all of them are considered medical devices. Understanding the difference matters, especially for companies developing connected health technology or planning future regulatory pathways.

What Defines a Medical Device vs a Wellness Device

At its core, the difference between a medical device and a wellness device comes down to intended use and claims. Medical devices are designed to diagnose, treat, or mitigate disease. Wellness devices are not.

A product may collect the same type of data in both categories. However, once a company claims that the data can be used to diagnose or manage a medical condition, it crosses into medical device territory. At that point, regulatory clearance becomes mandatory.

Why Claims Matter More Than Hardware

One of the most important takeaways from this discussion is that hardware alone does not determine classification. Two devices can be technically identical. What changes everything is what the manufacturer says the device can do.

Wellness devices can report general information, such as activity or trends, without proving medical accuracy. Medical devices must demonstrate that their outputs are accurate, reliable, and trustworthy enough for clinical decision making. Because of this, regulators require evidence that clinicians can rely on the data.

Apple Watch vs Fitness Trackers as Real-World Examples

Despite the added complexity, many companies choose to pursue medical device clearance. Reimbursement is one major reason. Another is market expectation. Consumers increasingly expect devices to provide reliable medical insights, not just raw data.

That claim alone places it firmly in the medical device category. Without clearance, making such a claim could trigger regulatory warnings. Apple pursued clearance because it enables reimbursement opportunities and meets growing consumer expectations for actionable medical insights.

Why Companies Choose the Medical Device Path

For those seeking deeper guidance, the FDA provides clear documentation outlining what qualifies as a wellness device and what does not. This guidance also explains which marketing claims are permitted in each category.

Where to Learn More

For those seeking deeper guidance, the FDA provides clear documentation outlining what qualifies as a wellness device and what does not. This guidance also explains which marketing claims are permitted in each category.

Older woman at home checking a smartwatch while managing medications, illustrating remote monitoring medical devices in daily life

Connected health devices are multiplying fast. We examine the gap between remote monitoring’s promise and its reality.

Two people seated at a table holding handheld medical device prototypes, with text overlay reading "Is It Ready for a Human?" — MedDevice by Design episode on clinical prototypes for human use

Ariana and Mark walk through what separates a clinical prototype from a proof-of-concept build, what determines how much testing and documentation you actually need, and where the regulatory line between significant risk and non-significant risk falls.

Nick and Nigel each holding a different USPTO patent certificate, illustrating the difference between a design patent and a utility patent in a Bio Break episode

In this episode of Bio Break, Nick walks through both patent types after receiving two of his own in the mail, one of each, from the USPTO.

Mickey Urdea and Scott Phillips headshots for MedTech Unscripted exit strategy webinar

Scott Phillips sits down with Mickey Urdea to examine what actually distinguishes companies that reach commercial outcomes from those that do not.